Heart Disease – Talk Bio

Cleerly Secures $192M for Heart Attack-Predicting AI Technology

6 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Cleerly, Coronary Artery Scanning, Heart Disease

Cleerly, AI, Heart Disease, Coronary Artery Scanning, Funding

Breakthrough in Heart Disease Treatment: Lilly’s Muvalaplin and Silence Therapeutics’ Zerlasiran Show Promising Results in Lowering Lipoprotein(a) Levels

7 months ago talkbio0Tagged Atherosclerosis, Cardiovascular system, Gene Silencing Therapy, Heart Disease, Interferes with, Lipoprotein(a ), Lp(a ), Muvalaplin, Risk, RNA, zerlasiran

Lipoprotein(a) (Lp(a)), Heart Disease, Muvalaplin, Zerlasiran, Cardiovascular Risk, Gene Silencing Therapy, RNA Interference, Atherosclerotic Cardiovascular Disease

Edgewise Therapeutics Sees 50% Stock Surge Following Positive Safety Data for Heart Disease Drug EDG-7500

9 months ago talkbio0Tagged Camzyos Rival, Cardiomyopathies, EDG-7500, Edgewise Therapeutics, Heart Disease, Safety, Stock Surge

Edgewise Therapeutics, EDG-7500, Heart Disease, Cardiomyopathy, Stock Surge, Safety Data, Camzyos Rival